Fulltext
Full text is available in the PDF.
IJ Psychiatry and Behavioral Sciences
IJPBS is the Official Journal of Mazandaran University of Medical Sciences
e-ISSN 1735-9287
p-ISSN 1735-8639
Image Credit:Iran J Psychiatry Behav Sci
Outline
Long-Acting Antipsychotics
Authors
1Retired Associate Professor of Tehran University of Medical Sciences and Health Services, Maymanat Psychiatric Hospital, Maymanat St., Azadi Blvd., Tehran, Iran
2Department of Psychiatry and Research Center for Psychiatry and Behavioral Sciences, Mazandaran University of Medical Sciences and Health Services, Sari, Iran
*Corresponding Author: Retired Associate Professor of Tehran University of Medical Sciences and Health Services, Maymanat Psychiatric Hospital, Maymanat St., Azadi Blvd., Tehran, Iran, Tel: +98-2166003474, Fax: +98-2166081294 Email: rezamirsepassi@yahoo.com
Published online:Dec 31, 2010
Article type:Editorial
Received:Mar 29, 2010
Accepted:Jun 04, 2010
How to Cite:Mir-Sepassi GR, Zarghami M. Long-Acting Antipsychotics. Iran J Psychiatry Behav Sci. 2010;4(2):. doi:
Abstract
Long-acting (depot) anti-psychotic injection (LAI) is an essential component of the treatment of schizophrenia. In this editorial, the journal tries to give a short account of the current ideas and practical aspects of LAI, with respect to the Iranian experience. Two categories of the Long-acting injections are discussed; mainly regarding their dosage, intervals of their injections and availabilities.
KeywordsAntipsychotics
References
- 1.References are available in the PDF.
Copyright
© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
30
Mar
2014
Depot Typical Antipsychotics versus Oral Atypical Antipsychotics in Relapse Rate Among Patients with Schizophrenia: A Five -Year Historical Cohort Study
Hamid-Reza Ahmadkhaniha,
Shahab Bani-Hashem,
Masoud Ahmadzad-Asl
Ahmadkhaniha H, Bani-Hashem S, Ahmadzad-Asl M. Depot Typical Antipsychotics versus Oral Atypical Antipsychotics in Relapse Rate Among Patients with Schizophrenia: A Five -Year Historical Cohort Study. Iran J Psychiatry Behav Sci. 2014;8(1):. doi:
4
Sep
2016
Methamphetamine-Associated Psychosis and Treatment With Haloperidol and Risperidone: A Pilot Study
Mercede Samiei,
Mohammad Vahidi,
Omid Rezaee,
Azadeh Yaraghchi,
Reza Daneshmand
Samiei M, Vahidi M, Rezaee O, Yaraghchi A, Daneshmand R. Methamphetamine-Associated Psychosis and Treatment With Haloperidol and Risperidone: A Pilot Study. Iran J Psychiatry Behav Sci. 2016;10(3):e7988. doi: https://doi.org/10.17795/ijpbs-7988
30
Jan
2007
Sodium Valproate as an Adjunctive Drug in Treatment of Schizophrenia
Victoria Omranifard,
Afsaneh Karbasi Amel,
Siamak Amanat
Omranifard V, Karbasi Amel A, Amanat S. Sodium Valproate as an Adjunctive Drug in Treatment of Schizophrenia. Iran J Psychiatry Behav Sci. 2007;1(1):. doi:
26
Jan
2026
Effects of Clozapine Add-On to Risperidone vs. Risperidone Monotherapy on Agitation in Paranoid Schizophrenia: A Quasi-experimental Pilot Study
Najmiatul Fitria,
Hidayatul Arief,
Yelly Oktavia Sari,
Syofyan Syofyan
Fitria N, Arief H, Oktavia Sari Y, Syofyan S. Effects of Clozapine Add-On to Risperidone vs. Risperidone Monotherapy on Agitation in Paranoid Schizophrenia: A Quasi-experimental Pilot Study. Iran J Psychiatry Behav Sci. 2026;20(1):e164189. doi: https://doi.org/10.5812/ijpbs-164189
30
Jun
2011
First-Episode Psychosis: An Overview of Research in Iran
Homayoun Amini
Amini H. First-Episode Psychosis: An Overview of Research in Iran. Iran J Psychiatry Behav Sci. 2011;5(1):. doi:
Cited by
- Scopus by DOI: 0
Last Update: 1 month ago
- Scopus by Title: 3
Last Update: 1 month ago
- Scopus by Title (Ref): 3
Last Update: 1 month ago
- CrossRef: 0
Last Update: 6 days ago
- OpenAlex: 0
Last Update: 1 day ago
- OpenCitations: 0
Last Update: 2 days ago
Comments
Number of Comments:0